Download PDF
Thromb Haemost 1998; 79(04): 879-880
DOI: 10.1055/s-0037-1615083
Letters to the Editor
Schattauer GmbH

Reduced Protein C Levels – a Contributory Factor for Stroke in Sickle Cell Disease

U. Khanduri
1   Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman
,
D. Gravell
1   Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman
,
B. S. Christie
1   Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman
,
Zakia Al Lamki
1   Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman
,
M. Zachariah
1   Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman
,
E. Cherian
1   Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman
› Author Affiliations
Further Information

Publication History

Received 24 April 1997

Accepted after revision 15 December 1997

Publication Date:
07 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical and therapeutic considerations. Semin Hematol 1991; 28: 213-9.
    PubMedGoogle Scholar
  • 2 El Hazmi MAF, Warsy AS, Bahakim H. Blood protein C and S in sickle cell disease. Acta Hematol 1993; 90: 114-9.
    CrossrefPubMedGoogle Scholar
  • 3 Peters M, Plaat BEC, ten Cate H, Wolters HJ, Weening RS, Brandjes DPM. Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost 1994; 71: 169-72.
    PubMedGoogle Scholar
  • 4 Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360-6.
    CrossrefPubMedGoogle Scholar
  • 5 Abboud MR, Jackson SM, Barredo J, Holden KR, Cure J, Laver J. Neurological complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplant 1996; 17: 405-7.
    PubMedGoogle Scholar
  • 6 Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier JP, Johnson FL, Lenarsky C, Powars D, Bunin N, Ohene-Frempong K, Wall D, Michel G, Plouvier E, Bodigoni P, Lutz P, Sanders JE, Mathews DC, Patience M, Appelbaum FR, Storb R. Neurological complications after allogeneic marrow transplantation for sickle cell anaemia. Blood 1995; 85 (Suppl. 04) 879-84.
    PubMedGoogle Scholar
  • 7 Wolters HJ, ten Cate H, Thomas LLM, Brandjes DPM, van der Ende A, van der Heidon Y, van Eps LWS. Low intensity oral anticoagulation in sickle cell diesease reverses the prethrombotic state: promises for treatment?. Br J Haematol 1995; 90: 715-7.
    CrossrefPubMedGoogle Scholar